SII plans to seek restricted emergency use permission of the vaccine in India. The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said on Friday. The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility. “The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis at its licensed Hadapsar facility with certain conditions,” an official source said.
Coronavirus | Decision on lockdown extension in Tamil Nadu to be announced on Saturday
Updated:
Updated:
Chief Secretary V. Irai Anbu, Director-General of Police J.K. Tripathy and senior officials participated.
Share Article
AAA
On Friday, Chief Minister M.K. Stalin chaired a meeting of officials to discuss the COVID-19 scenario and the lockdown restrictions across the State. | Photo Credit:
DIPR
Chief Secretary V. Irai Anbu, Director-General of Police J.K. Tripathy and senior officials participated. The Tamil Nadu government would on Saturday announce whether the ongoing intense COVID-19 lockdown in the State would be extended beyond the morning of June 7 or not.